Looking back on his research, the Japanese laureate highlighted his discovery in 1995 of the molecular marker for “regulatory T cells” that suppress excessive immune responses.
“It was kind of fun” to see the importance of the cells in actual disease settings, organ transplantation and also cancer immunity, he said.
Referring to prospects, Sakaguchi said that his research is still in an early stage for clinical application and that developing new treatments will take time.